- Current report filing (8-K)
08 Décembre 2011 - 10:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
December 8, 2011 (December 7, 2011)
ALLOS THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
|
000-29815
|
|
54-1655029
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
11080 CirclePoint Road, Suite 200
Westminster, Colorado
|
|
80020
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(303) 426-6262
Not applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 1 Registrants Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.
On December 7, 2011, Allos Therapeutics, Inc. (the Company) entered into a Sixth Amendment to Office Lease Agreement (the Sixth Lease Amendment) to its Office Lease, dated April 23, 2001, as previously amended (the Existing Lease Agreement), with Circle Point Properties, LLC (Landlord), successor to Catellus Development Corporation. The Existing Lease Agreement, as amended by the Sixth Lease Amendment is hereinafter referred to as the Lease Agreement.
Pursuant to the Sixth Lease Amendment, the Company and Landlord agreed to extend the term of the Lease Agreement from and after February 1, 2012 for a period of twelve (12) months to expire January 31, 2013. The Company and Landlord further agreed to reduce the number of rentable square feet included in the leased premises to approximately 31,248 square feet. The premises leased under the Lease Agreement is the premises commonly known as Suite 200 located in the office building located at 11080 Circle Point Road, Westminster, Colorado 80020.
Except as provided in the Sixth Lease Amendment, all other terms of the Existing Lease Agreement remain in full force and effect.
The foregoing summary is qualified in its entirety by reference to the Sixth Lease Amendment, which will be attached as an exhibit to the Companys Annual Report on Form 10-K for the period ended December 31, 2011.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: December 8, 2011
|
|
ALLOS THERAPEUTICS, INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Marc H. Graboyes
|
|
|
Marc H. Graboyes
|
|
Its:
|
Senior Vice President, General Counsel and Secretary
|
3
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024